問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
李政學
下載
2021-12-30 - 2027-04-30
Condition/Disease
Test Drug
Participate Sites6Sites
Recruiting6Sites
2021-01-01 - 2029-10-31
Participate Sites7Sites
Recruiting7Sites
2020-06-01 - 2026-12-31
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Characterised by PTEN deficiency
Capivasertib Abiraterone
Participate Sites9Sites
Recruiting9Sites
2021-02-26 - 2025-12-10
Participate Sites5Sites
Recruiting5Sites
2022-08-01 - 2026-08-31
2021-06-01 - 2022-05-30
2021-08-01 - 2028-01-30
Not yet recruiting4Sites
Recruiting3Sites
全部
